Sodium
In clinical developmentAlso known as Na - Sodium.
Recent clinical, regulatory, research and industry developments relating to this drug.
Acetazolamide in Acute Decompensated Heart Failure with Volume Overload.
Na+ tolerance and Na+ transport in higher plants.
Profile
Canonical identifiers, marketed brand names and mechanism, resolved across RxNorm, ChEMBL and ATC.
Clinical trials
The current development programme across all trial phases — status mix, phase distribution and the late-stage studies shaping the evidence base.
Recent completions
Trials that read out recently, adding to the completed evidence base.
Research activity
Key research shaping understanding of this drug, combining the latest publications with the most influential evidence.
Major research themes7
Journals, researchers & institutions
- Annals of botany1
- Frontiers in endocrinology1
- The New England journal of medicine1
- Blouard P1
- Bruckers L1
- Chen H1
- Chen J1
- Chen Z1
- Chenot F1
- Damman K1
- Dauw J1
- Hasselt University1
- National Clinical Research Center for Geriatric Disorders1
- University of Cambridge1
- Xiangya Hospital1
- Yale University School of Medicine1
Related drugs
Drugs sharing diseases, protein targets and literature with this one. Ranked by graph evidence (shared targets + diseases weighted above co-mentions).
Studied across 4 of the same disease areas as Sodium in the shared literature.
- RxNorm (U.S. National Library of Medicine) — drug identity
- Europe PMC — research literature
- ClinicalTrials.gov — clinical trials